Starting the Marshall Protocol

The Marshall Protocol (MP) is a powerful treatment plan and must be followed exactly. Every aspect of the MP is designed with a patient's safety in mind. Patients intent on beginning the MP should first ensure that they have completed all the items on the checklist before they begin.

Patients on the Marshall Protocol (MP) must work with a licensed physician or other healthcare practitioner, such as a nurse practitioner or physician's assistant. Patients who have the most successful outcomes are proactive and prepared. They internalize the requirements for the MP and, when necessary, work to address any of their physicians' concerns about the treatment. At this point, no doctors are certified in the use of the MP.

Generally speaking, it may make more sense to convince one's existing doctor before trying to find a new one. However, Autoimmunity Research Foundation maintains a list of doctors who are or have been willing to prescribe the Marshall Protocol. The list of local MP doctors is available upon request by posting at CureMyTh1.org.

Note that at this point, no doctors are certified in the use of the Marshall Protocol. For this reason, it is important that MP patients familiarize themselves with the stated guidelines.

Used in the context of the Marshall Protocol (MP), a therapeutic probeA brief trial of the Marshall Protocol to see if it will generate an immunopathological response. The "gold standard" for testing whether a patient is a good candidate for the MP. refers to a brief trial of the MP, in which patients take regular doses of olmesartan (Benicar) with pulsed, low doses of antibiotics and restrict consumption of vitamin D. The presence of a positive treatment response is taken as an indication that a patient is sick with Th1 disease and that the MP is a treatment option for that disease. Although there are other factors and variables, which can strongly suggest the presence of Th1 disease, the therapeutic probe is currently the “gold standard” for diagnosis of Th1 disease.

In the context of the therapeutic probe, there are at least three responses or types of responses which indicate that continued treatment with the MP is warranted:

• photosensitivityAbnormal sensitivity to sunlight and bright lights. Also referred to as "sun flare" or "light flare." – Even if patients have never been light sensitive before, they may find lights to be too bright for comfort.
• noticeable spike in symptoms – An activator of the innate immune responseThe body's first line of defense against intracellular and other pathogens. According to the Marshall Pathogenesis the innate immune system becomes disabled as patients develop chronic disease., Benicar works with minocycline to kill pathogenic bacteria. The effect of a strengthened immune system response is called immunopathology. Immunopathology feels bad because the killing of bacteria generates cytokinesAny of various protein molecules secreted by cells of the immune system that serve to regulate the immune system., endotoxins, and nitric oxide.
• noticeable relief in symptoms – As an ARB, Benicar has profound anti-inflammatory effects, which manifest in a reduction in pain, fatigue, and other symptoms of Th1 disease.

Symptoms which wax and wane in tandem with the every-other-day administration of antibiotics are an especially strong indication of Th1 disease.

It is expected that the way a patient responds to the MP will change over time.